 | • レポートコード：GIR-105X02573 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、双極性障害治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。双極性障害治療薬の種類別市場規模（オランザピン（ジプレキサ）、クエチアピン（セロクエル）、リスペリドン（リスペリドン）、アリピプラゾール（アビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザピン））、用途別市場規模（ルマテペロン、中枢神経系（CNS）障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・双極性障害治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Allergan、Bristol-Myers Squibb、GSK、Janssen、AbbVie、Youdim、Delpor、Lundbeck、Intra-Cellular Therapies、Novartis Pharmaceuticals Corporation、Noven Pharmaceuticals、Otsuka、Pfizer、Reviva Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：オランザピン（ジプレキサ）、クエチアピン（セロクエル）、リスペリドン（リスペリドン）、アリピプラゾール（アビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザピン） ・用途別分析2016年-2026年：ルマテペロン、中枢神経系（CNS）障害 ・双極性障害治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・双極性障害治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・双極性障害治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・双極性障害治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・双極性障害治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Bipolar Disorder Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Bipolar Disorder Therapeutics Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Bipolar Disorder Therapeutics Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Bipolar Disorder Therapeutics Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ariprazole (Abilify)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Market segment by Application can be divided into
lumateperone
Central Nervous System (CNS) Disorders
The key market players for global Bipolar Disorder Therapeutics Drugs market are listed below:
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Bipolar Disorder Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Bipolar Disorder Therapeutics Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Olanzapine (Zyprexa)
1.2.3 Quetiapine (Seroquel)
1.2.4 Risperidone (Risperdal)
1.2.5 Ariprazole (Abilify)
1.2.6 Ziprasidone (Geodon)
1.2.7 Clozapine (Clozaril)
1.3 Market Analysis by Application
1.3.1 Overview: Global Bipolar Disorder Therapeutics Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 lumateperone
1.3.3 Central Nervous System (CNS) Disorders
1.4 Global Bipolar Disorder Therapeutics Drugs Market Size & Forecast
1.4.1 Global Bipolar Disorder Therapeutics Drugs Sales in Value (2016-2026))
1.4.2 Global Bipolar Disorder Therapeutics Drugs Sales in Volume (2016-2026)
1.4.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Bipolar Disorder Therapeutics Drugs Production Capacity Analysis
1.5.1 Global Bipolar Disorder Therapeutics Drugs Total Production Capacity (2016-2026)
1.5.2 Global Bipolar Disorder Therapeutics Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Bipolar Disorder Therapeutics Drugs Market Drivers
1.6.2 Bipolar Disorder Therapeutics Drugs Market Restraints
1.6.3 Bipolar Disorder Therapeutics Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Product and Services
2.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Bipolar Disorder Therapeutics Drugs Product and Services
2.2.4 Allergan Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product and Services
2.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Bipolar Disorder Therapeutics Drugs Product and Services
2.4.4 GSK Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Janssen
2.5.1 Janssen Details
2.5.2 Janssen Major Business
2.5.3 Janssen Bipolar Disorder Therapeutics Drugs Product and Services
2.5.4 Janssen Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Product and Services
2.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Youdim
2.7.1 Youdim Details
2.7.2 Youdim Major Business
2.7.3 Youdim Bipolar Disorder Therapeutics Drugs Product and Services
2.7.4 Youdim Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Delpor
2.8.1 Delpor Details
2.8.2 Delpor Major Business
2.8.3 Delpor Bipolar Disorder Therapeutics Drugs Product and Services
2.8.4 Delpor Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Lundbeck
2.9.1 Lundbeck Details
2.9.2 Lundbeck Major Business
2.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Product and Services
2.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Intra-Cellular Therapies
2.10.1 Intra-Cellular Therapies Details
2.10.2 Intra-Cellular Therapies Major Business
2.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product and Services
2.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Novartis Pharmaceuticals Corporation
2.11.1 Novartis Pharmaceuticals Corporation Details
2.11.2 Novartis Pharmaceuticals Corporation Major Business
2.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product and Services
2.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Noven Pharmaceuticals
2.12.1 Noven Pharmaceuticals Details
2.12.2 Noven Pharmaceuticals Major Business
2.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
2.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Otsuka
2.13.1 Otsuka Details
2.13.2 Otsuka Major Business
2.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Product and Services
2.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business
2.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Product and Services
2.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Reviva Pharmaceuticals
2.15.1 Reviva Pharmaceuticals Details
2.15.2 Reviva Pharmaceuticals Major Business
2.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
2.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Bipolar Disorder Therapeutics Drugs Sales by Manufacturer
3.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Bipolar Disorder Therapeutics Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Bipolar Disorder Therapeutics Drugs Manufacturer Market Share
3.4.2 Top 6 Bipolar Disorder Therapeutics Drugs Manufacturer Market Share
3.5 Global Bipolar Disorder Therapeutics Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Bipolar Disorder Therapeutics Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Region
4.1.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2026)
4.2 North America Bipolar Disorder Therapeutics Drugs Revenue (2016-2026)
4.3 Europe Bipolar Disorder Therapeutics Drugs Revenue (2016-2026)
4.4 Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue (2016-2026)
4.5 South America Bipolar Disorder Therapeutics Drugs Revenue (2016-2026)
4.6 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Type (2016-2026)
5.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2016-2026)
5.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Bipolar Disorder Therapeutics Drugs Sales in Volume by Application (2016-2026)
6.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2016-2026)
6.3 Global Bipolar Disorder Therapeutics Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2026)
7.2 North America Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2026)
7.3 North America Bipolar Disorder Therapeutics Drugs Market Size by Country
7.3.1 North America Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2026)
8.2 Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2026)
8.3 Europe Bipolar Disorder Therapeutics Drugs Market Size by Country
8.3.1 Europe Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Bipolar Disorder Therapeutics Drugs Market Size by Region
9.3.1 Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2026)
10.2 South America Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2026)
10.3 South America Bipolar Disorder Therapeutics Drugs Market Size by Country
10.3.1 South America Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Bipolar Disorder Therapeutics Drugs Market Size by Country
11.3.1 Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Bipolar Disorder Therapeutics Drugs Typical Distributors
12.3 Bipolar Disorder Therapeutics Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Bipolar Disorder Therapeutics Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Bipolar Disorder Therapeutics Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Bipolar Disorder Therapeutics Drugs Product and Services
Table 6. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Bipolar Disorder Therapeutics Drugs Product and Services
Table 10. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product and Services
Table 14. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GSK Basic Information, Manufacturing Base and Competitors
Table 16. GSK Major Business
Table 17. GSK Bipolar Disorder Therapeutics Drugs Product and Services
Table 18. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Janssen Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Major Business
Table 21. Janssen Bipolar Disorder Therapeutics Drugs Product and Services
Table 22. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. AbbVie Basic Information, Manufacturing Base and Competitors
Table 24. AbbVie Major Business
Table 25. AbbVie Bipolar Disorder Therapeutics Drugs Product and Services
Table 26. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Youdim Basic Information, Manufacturing Base and Competitors
Table 28. Youdim Major Business
Table 29. Youdim Bipolar Disorder Therapeutics Drugs Product and Services
Table 30. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Delpor Basic Information, Manufacturing Base and Competitors
Table 32. Delpor Major Business
Table 33. Delpor Bipolar Disorder Therapeutics Drugs Product and Services
Table 34. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 36. Lundbeck Major Business
Table 37. Lundbeck Bipolar Disorder Therapeutics Drugs Product and Services
Table 38. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Intra-Cellular Therapies Basic Information, Manufacturing Base and Competitors
Table 40. Intra-Cellular Therapies Major Business
Table 41. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product and Services
Table 42. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Novartis Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Pharmaceuticals Corporation Major Business
Table 45. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product and Services
Table 46. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Noven Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Noven Pharmaceuticals Major Business
Table 49. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
Table 50. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Otsuka Basic Information, Manufacturing Base and Competitors
Table 52. Otsuka Major Business
Table 53. Otsuka Bipolar Disorder Therapeutics Drugs Product and Services
Table 54. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Bipolar Disorder Therapeutics Drugs Product and Services
Table 58. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Reviva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Reviva Pharmaceuticals Major Business
Table 61. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product and Services
Table 62. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 64. Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Bipolar Disorder Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Bipolar Disorder Therapeutics Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Bipolar Disorder Therapeutics Drugs Production Site of Key Manufacturer
Table 68. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2016-2021e) & (K Units)
Table 69. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2021-2026) & (K Units)
Table 70. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Bipolar Disorder Therapeutics Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 77. Global Bipolar Disorder Therapeutics Drugs Price by Type (2021-2026) & (USD/Unit)
Table 78. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Bipolar Disorder Therapeutics Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 83. Global Bipolar Disorder Therapeutics Drugs Price by Application (2021-2026) & (USD/Unit)
Table 84. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2021-2026) & (K Units)
Table 86. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2021-2026) & (K Units)
Table 90. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2021-2026) & (K Units)
Table 94. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2016-2021e) & (K Units)
Table 101. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2021-2026) & (K Units)
Table 106. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2021-2026) & (K Units)
Table 108. South America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. South America Bipolar Disorder Therapeutics Drugs Sales by Country (2021-2026) & (K Units)
Table 110. South America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Bipolar Disorder Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. South America Bipolar Disorder Therapeutics Drugs Sales by Type (2021-2026) & (K Units)
Table 114. South America Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. South America Bipolar Disorder Therapeutics Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021e) & (K Units)
Table 117. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021e) & (K Units)
Table 121. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2021-2026) & (K Units)
Table 122. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021e) & (K Units)
Table 123. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2021-2026) & (K Units)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Bipolar Disorder Therapeutics Drugs Typical Distributors
Table 127. Bipolar Disorder Therapeutics Drugs Typical Customers
List of Figures
Figure 1. Bipolar Disorder Therapeutics Drugs Picture
Figure 2. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020
Figure 3. Olanzapine (Zyprexa)
Figure 4. Quetiapine (Seroquel)
Figure 5. Risperidone (Risperdal)
Figure 6. Ariprazole (Abilify)
Figure 7. Ziprasidone (Geodon)
Figure 8. Clozapine (Clozaril)
Figure 9. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020
Figure 10. lumateperone
Figure 11. Central Nervous System (CNS) Disorders
Figure 12. Global Bipolar Disorder Therapeutics Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Bipolar Disorder Therapeutics Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Bipolar Disorder Therapeutics Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Bipolar Disorder Therapeutics Drugs Sales (2016-2026) & (K Units)
Figure 34. Global Bipolar Disorder Therapeutics Drugs Production Capacity (2016-2026) & (K Units)
Figure 35. Global Bipolar Disorder Therapeutics Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Bipolar Disorder Therapeutics Drugs Market Drivers
Figure 37. Bipolar Disorder Therapeutics Drugs Market Restraints
Figure 38. Bipolar Disorder Therapeutics Drugs Market Trends
Figure 39. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturer in 2020
Figure 40. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Manufacturer in 2020
Figure 41. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Bipolar Disorder Therapeutics Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Bipolar Disorder Therapeutics Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2026)
Figure 45. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 46. North America Bipolar Disorder Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Europe Bipolar Disorder Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 49. South America Bipolar Disorder Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 52. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2016-2026)
Figure 53. Global Bipolar Disorder Therapeutics Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 55. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2016-2026)
Figure 56. Global Bipolar Disorder Therapeutics Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 58. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 59. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 60. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 61. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 62. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 63. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 64. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 70. South America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 71. South America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 72. South America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
双極性障害の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…- 睡眠障害治療薬の世界市場2018-2025 Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.Factors such as increasing incidences of depression and other medical disorders, late night working schedule, busy lifestyle, lack of qua…
- 世界の非定型抗精神病薬市場 2021：企業別、地域別、種類・用途別 The Atypical Antipsychotic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 静脈血栓塞栓症治療薬の世界市場2018-2025 In 2018, the global Venous Thromboembolism Therapeutics Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Venous Thr…
- 頭頸部がん：頭頸部がん薬物療法の世界市場2018-2025 Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private …